Prognostic value of high-dose dipyridamole stress myocardial contrast perfusion echocardiography

Circulation

Volumn 126, Issue 10, 2012, Pages 1217-1224

  Gaibazzi, Nicola ^a   Reverberi, Claudio ^a   Lorenzoni, Valentina ^b   Molinaro, Sabrina ^b   Porter, Thomas R ^c  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

coronary artery disease; dipyridamole; myocardial contrast echocardiography; prognosis; stress echocardiography

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPYRIDAMOLE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTRAST ECHOCARDIOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIPYRIDAMOLE REAL TIME CONTRAST ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR;

AGED; CONTRAST MEDIA; CORONARY ARTERY DISEASE; DIPYRIDAMOLE; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VASODILATOR AGENTS;

EID: 84865863386     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.110031     Document Type: Article

References (23)

1. Sicari R, Nihoyannopoulos P, Evangelista A, Kasprzak J, Lancellotti P, Poldermans D, Voigt JU, Zamorano JL; European Association of Echocardiography. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr. 2008;9:415-437.
2. Pellikka PA, Nagueh SF, Elhendy AA, Kuehl CA, Sawada SG; American Society of Echocardiography. American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J Am Soc Echocardiogr. 2007;20:1021-1041.
3. Steinberg EH, Madmon L, Patel CP, Sedlis SP, Kronzon I, Cohen JL. Long-term prognostic significance of dobutamine echocardiography in patients with suspected coronary artery disease: results of a 5-year follow-up study. J Am Coll Cardiol. 1997;29:969-973.
4. Krivokapich J, Child JS, Walter DO, Garfinkel A. Prognostic value of dobutamine stress echocardiography in predicting cardiac events in patients with known or suspected coronary artery disease. J Am Coll Cardiol. 1999;33:708-716.
5. Marwick TH, Case C, Sawada S, Rimmerman C, Brenneman P, Kovacs R, Short L, Lauer M. Prediction of mortality using dobutamine echocardiography. J Am Coll Cardiol. 2001;37:754-760.
6. Sicari R, Pasanisi E, Venneri L, Landi P, Cortigiani L, Picano E; Echo Persantine International Cooperative (EPIC) Study Group; Echo Dobutamine International Cooperative (EDIC) Study Group. Stress echo results predict mortality: a large-scale multicenter prospective international study. J Am Coll Cardiol. 2003;41:589-595.
7. Cortigiani L, Bigi R, Landi P, Bovenzi F, Picano E, Sicari R. Prognostic implication of stress echocardiography in 6214 hypertensive and 5328 normotensive patients. Eur Heart J. 2011;32:1509-1518.
8. Gaibazzi N, Rigo F, Reverberi C. Detection of coronary artery disease by combined assessment of wall motion, myocardial perfusion and coronary flow reserve: a multiparametric contrast stress-echocardiography study. J Am Soc Echocardiogr. 2010;23:1242-1250.
9. Lipiec P, Wejner-Mik P, Krzemińska-Pakuła M, Kuoemierek J, Płachcińska A, Szumiński R, Peruga JZ, Kasprzak JD. Accelerated stress real-time myocardial contrast echocardiography for the detection of coronary artery disease: comparison with 99mTc single photon emission computed tomography. J Am Soc Echocardiogr. 2008;21:941-947.
10. Gaibazzi N, Squeri A, Reverberi C, Molinaro S, Lorenzoni V, Sartorio D, Senior R. Contrast stress-echocardiography predicts cardiac events in patients with suspected acute coronary syndrome but nondiagnostic electrocardiogram and normal 12-hour troponin. J Am Soc Echocardiogr. 2011;24:1333-1341.
11. Dawson D, Kaul S, Peters D, Rinkevich D, Schnell G, Belcik JT, Wei K. Prognostic value of dipyridamole stress myocardial contrast echocardiography: comparison with single photon emission computed tomography. J Am Soc Echocardiogr. 2009;22:954-960.
12. Wejner-Mik P, Lipiec P, Kasprzak JD. Long-term prognostic value of dipyridamole stress myocardial contrast echocardiography. Eur J Echocardiogr. 2011;12:762-766.
13. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(suppl 1):S5-S20.
14. Rafter P, Phillips P, Vannan MA. Imaging technologies and techniques. Cardiol Clin. 2004;22:181-197.
15. Lauer MS, Blackstone EH, Young JB, Topol EJ. Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol. 1999;34: 618-620.
16. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27: 157-172.
17. Hachamovitch R, Di Carli MF. Methods and limitations of assessing new noninvasive tests. Part II: Outcomes-based validation and reliability assessment of noninvasive testing. Circulation. 2008;117: 2793-2801.
18. Tsutsui JM, Elhendy A, Anderson JR, Xie F, McGrain AC, Porter TR. Prognostic value of dobutamine stress myocardial contrast perfusion echocardiography. Circulation. 2005;112:1444-1450.
19. Tsutsui JM, Xie F, Cloutier D, Kalvaitis S, Elhendy A, Porter TR. Real-time dobutamine stress myocardial perfusion echocardiography predicts outcome in the elderly. Eur Heart J. 2008;29:377-385.
20. Bingham SE, Hachamovitch R. Incremental prognostic significance of combined cardiac magnetic resonance imaging, adenosine stress perfusion, delayed enhancement, and left ventricular function over preimaging information for the prediction of adverse events. Circulation. 2011;123:1509-1518.
21. Bodi V, Sanchis J, Lopez-Lereu MP, Nunez J, Mainar L, Monmeneu JV, Ruiz V, Rumiz E, Husser O, Moratal D, Millet J, Chorro FJ, Llacer A. Prognostic and therapeutic implications of dipyridamole stress cardiovascular magnetic resonance on the basis of the ischaemic cascade. Heart. 2009;95:49-55.
22. Einstein AJ, Weiner SD, Bernheim A, Kulon M, Bokhari S, Johnson LL, Moses JW, Balter S. Multiple testing, cumulative radiation dose, and clinical indications in patients undergoing myocardial perfusion imaging. JAMA. 2010;304:2137-2144.
23. Tsutsui J, Xie F, McGrain AC, Mahrous H, Hankins J, O'Leary EL, Porter TR. Comparison of low mechanical index pulse sequence schemes for detecting myocardial perfusion abnormalities during vasodilator stress echocardiography. Am J Cardiol. 2005;95:565-70.